Gao J, Gurbuxani S, Zak T, Kocherginsky M, et al. Comparison of myeloid neoplasms with nonclassic 3q26.2/MECOM versus classic inv(3)/t(3;3) rearrangements reveals diverse clinicopathologic features, genetic profiles, and molecular mechanisms of MECOM activation. Genes Chromosomes Cancer 2022;61:71-80.
PMID: 34668265